https://www.selleckchem.com/pr....oducts/ifenprodil-ta
he high prevalence of CE in both oncology and vascular service patients as well as the disparities in management. In addition, there is a high incidence of cellulitis reported that is possibly not surprising given the low number of patients receiving full lymphedema care. Good data collection is essential if we are to provide and fund a comprehensive service in the future.Objectives To identify predictive factors associated with limb volume reduction using different decongestive lymphatic therapy (DLT) systems in patients wi